MATINAS BIOPHARMA HOLDINGS, INC. Payments of Financing Costs
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Payments of Financing Costs of $29.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. payments of financing costs for the quarter ending 2025-12-31 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. payments of financing costs for the quarter ending 2025-09-30 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. payments of financing costs for the quarter ending 2025-06-30 was $27.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. payments of financing costs for the quarter ending 2025-03-31 was $2.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. payments of financing costs for fiscal 2025 was $29.00K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $27.00K derived: sum of 3 quarters · filed 2026-08-13 | $29.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $27.00K derived: sum of 2 quarters · filed 2026-08-13 | $29.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $29.00K 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $2.00K 10-Q · filed 2026-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |